Corebridge DECO II, LLC - 06 Feb 2024 Form 4 Insider Report for Fractyl Health, Inc. (GUTS)

Role
10%+ Owner
Signature
/s/ Atif Mahmood, Chief Financial Officer, SAFG Capital LLC as Managing Member of Corebridge Investments Fund Holdings, LLC as Manager of Corebridge DECO II, LLC
Issuer symbol
GUTS
Transactions as of
06 Feb 2024
Net transactions value
$0
Form type
4
Filing time
08 Feb 2024, 16:51:35 UTC
Previous filing
01 Feb 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GUTS Common Stock Conversion of derivative security +673,391 673,391 06 Feb 2024 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GUTS Series E Preferred Shares Conversion of derivative security $0 -1,172,236 -100% $0.000000* 0 06 Feb 2024 Common Stock 546,242 Direct F1, F2
transaction GUTS Series F Preferred Shares Conversion of derivative security $0 -272,863 -100% $0.000000* 0 06 Feb 2024 Common Stock 127,149 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Corebridge DECO II, LLC is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 The Series E Convertible Preferred Stock and Series F Convertible Preferred Stock (together, the "Preferred Shares") automatically converted into shares of the Issuer's common stock, for no additional consideration, immediately prior to the closing of the Issuer's initial public offering of common stock, at a conversion ratio of 1 share of Common Stock for 2.146 Preferred Shares. The Preferred Shares had no expiration date.
F2 Corebridge DECO II, LLC is an indirect subsidiary of American International Group, Inc.